anmelden
OMX Stockholm PI
1.064,20
PKT
+1,74
PKT
+0,16
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Stockholm PI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 17.10.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 17.10.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 17.10.17 | ABB (Asea Brown Boveri) Sell | UBS AG | |
| 17.10.17 | Volvo (B) Neutral | UBS AG | |
| 16.10.17 | Nokia Neutral | Citigroup Corp. | |
| 16.10.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 16.10.17 | AstraZeneca Outperform | Credit Suisse Group | |
| 12.10.17 | Nokia buy | UBS AG | |
| 12.10.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | UBS AG | |
| 12.10.17 | Nokia buy | Goldman Sachs Group Inc. | |
| 11.10.17 | AstraZeneca buy | Deutsche Bank AG | |
| 11.10.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | JP Morgan Chase & Co. | |
| 11.10.17 | ABB (Asea Brown Boveri) Hold | HSBC | |
| 10.10.17 | Nokia buy | UBS AG | |
| 10.10.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 09.10.17 | Volvo (B) Underweight | Morgan Stanley | |
| 09.10.17 | AstraZeneca Neutral | UBS AG | |
| 09.10.17 | AstraZeneca Reduce | HSBC | |
| 05.10.17 | Nokia overweight | Morgan Stanley | |
| 05.10.17 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 03.10.17 | Ericsson (Telefon L.M.Ericsson) (B) Underperform | Credit Suisse Group | |
| 02.10.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 27.09.17 | Nokia buy | Société Générale Group S.A. (SG) | |
| 26.09.17 | ABB (Asea Brown Boveri) Sell | Citigroup Corp. | |
| 26.09.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 26.09.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 25.09.17 | AstraZeneca Outperform | BNP PARIBAS | |
| 25.09.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 22.09.17 | Nokia Underperform | BNP PARIBAS | |
| 22.09.17 | AstraZeneca Outperform | Bernstein Research | |
| 19.09.17 | Nokia buy | UBS AG | |
| 19.09.17 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.09.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 14.09.17 | Nokia buy | Goldman Sachs Group Inc. | |
| 13.09.17 | AstraZeneca overweight | Barclays Capital | |
| 13.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 13.09.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 12.09.17 | Volvo (B) Neutral | UBS AG | |
| 11.09.17 | AstraZeneca Neutral | UBS AG | |
| 11.09.17 | AstraZeneca Hold | Jefferies & Company Inc. |